Qing Zhang

Southwestern Medical Center — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

77h-index22.0kcitations1.0kworks3.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer, Hypoxia, and Metabolism(138), RNA modifications and cancer(126), Epigenetics and DNA Methylation(70), Cancer, Lipids, and Metabolism(64), MicroRNA in disease regulation(52)

Publications1.0k total

A Switch in Iron Delivery Is Critical for Postnatal Kidney Development
Kidney360·2026Open Access
Direct Observation of Antisite Defects and the Induced Ferroelectricity in Antiferroelectric PbHfO <sub>3</sub>
ACS Applied Materials & Interfaces·2025
GLUL Confers Perivascular Cancer‐Associated Fibroblasts With Pro‐Angiogenic Capacity to Promote Glioma Progression
Advanced Science·2025Open Access
Identifying psychiatric manifestations in outpatients with depression and anxiety: a large language model-based approach
npj Mental Health Research·2025· 1 citedOpen Access
Pulsed electromagnetic fields inhibit atherosclerosis by regulating pyroptosis through membrane tension-mediated mechanosensitive channels
Signal Transduction and Targeted Therapy·2025Open Access
Table S2 from HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans
2025Open Access
Figure S7 from HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans
2025Open Access
INFLUENCE OF DOSE-AVERAGED LINEAR ENERGY TRANSFER AND BIOLOGICAL EQUIVALENT DOSE ON TUMOUR CONTROL AFTER CARBON-ION RADIOTHERAPY FOR UNRESECTABLE SACROCOCCYGEAL CHORDOMA
International Journal of Particle Therapy·2025Open Access
Supplementary Data Legend LS1 from HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans
2025Open Access
Figure S4 from HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans
2025Open Access
Table S1 from HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans
2025Open Access
Figure S8 from HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans
2025Open Access
Figure S5 from HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans
2025Open Access
Figure S3 from HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans
2025Open Access
Figure S1 from HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans
2025Open Access
Figure S2 from HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans
2025Open Access
Figure S6 from HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans
2025Open Access
ELPO: Ensemble Learning Based Prompt Optimization for Large Language Models
arXiv (Cornell University)·2025Open Access
Panel-by-Panel Souls: A Performative Workflow for Expressive Faces in AI-Assisted Manga Creation
arXiv (Cornell University)·2025Open Access
DLL1-responsive PD-L1 <sup>+</sup> tumor-associated macrophages promote endocrine resistance in breast cancer
Science Translational Medicine·2025
page 1 of 52Next →

Frequent Co-authors

William G. Kaelin(8), Sabina Signoretti(4), Samir Hanash(4), Sichuan Xi(4), Thomas E. Smithgall(4), William E. Gooding(4), Bing Wang(3), Jin Jiang(3), Steven M. Greenberg(3), Edward K. Novak(3), Richard A. Spritz(3), Richard T. Swank(3), Vítor M. Faça(3), Alice Chin(3), Chee‐Hong Wong(3), Xingnan Zheng(3), Chengheng Liao(3), Sufi M. Thomas(3), Jill M. Siegfried(3), Jennifer R. Grandis(3)